Prime Therapeutics

Type: Company
Name: Prime Therapeutics
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

Gilead Sciences : Prime Therapeutics responds to FDA approval of Gilead's latest Hepatitis C drug

By a News Reporter-Staff News Editor at Pharma Business Week -- Today's U.S. Food and Drug Administration (FDA) approval of Gilead's new, fixed-dose, combination Hepatitis C drug signals another spike in treatment and pharmacy costs for health plans across ... [Published 4 Traders - Oct 23 2014]
First reported Oct 22 2014 - Updated Oct 22 2014 - 1 reports

Drug coupons shrink patients' costs considerably

(HealthDay)—Drug coupons could reduce patients' out-of-pocket costs by 60 percent, according to a study published in the October issue of Health Affairs.Catherine I. Starner, Pharm.D., from Prime Therapeutics in Eagan, Minn., and colleagues utilized an ... [Published Medical Xpress - Oct 22 2014]
First reported Oct 13 2014 - Updated Oct 13 2014 - 1 reports

Payers hit back at Gilead for $94,500 price tag on brand-new hep C combo pill

So you thought Gilead's ($GILD) Sovaldi was expensive? Get ready for Harvoni, the company's all-oral hep C combo regimen that won FDA approval on Friday. The cost? $94,500 for a 12-week course of treatment.Courtesy of GileadThe price for the cocktail--which ... [Published FiercePharma - Oct 13 2014]
First reported Oct 12 2014 - Updated Oct 12 2014 - 1 reports

Movers and Shakers: Duane Barnes, Prime Therapeutics

A look at the people behind the numbers in area business:DUANE BARNES PRIME THERAPEUTICSTitle: Chief operating officerAge: 54Duane Barnes is adding to his responsibilities at Prime Therapeutics with his promotion to chief operating officer at the St. ... [Published Minneapolis Star Tribune - Oct 12 2014]
First reported Oct 10 2014 - Updated Oct 11 2014 - 4 reports

Prime Therapeutics responds to FDA approval of Gilead's latest Hepatitis C drug

ST. PAUL, Minn."When Sovaldi launched earlier this year, we saw a dramatic increase in prescriptions for the drug," said Peter WickershamWickersham added that the new Gilead Sciences, Inc. (Gilead) combination drug– ledipasvir + sofosbuvir (Sovaldi®) ... [Published Bio-Medicine - Oct 11 2014]
First reported Oct 10 2014 - Updated Oct 10 2014 - 1 reports

Click Here For Links From Oct. 10, 2014

WCCO 4 News At 10Good QuestionGood Question Submission FormWCCO This MorningWho’s Hiring?Prime Therapeutics: Senior Clinical Pharmacist- SpecialtyApollo Heating and Air Conditioning: HVAC Technicians/ InstallersFree Bikes 4 KidzClick here for more information ... [Published CBS Minnesota - Oct 10 2014]
First reported Oct 09 2014 - Updated Oct 09 2014 - 2 reports

Duane Barnes, Prime Therapeutics' COO, Joins NASP / SPAARx Board of Directors

About the National Association of Specialty Pharmacy (NASP) / Specialty Pharmacy Association of America (SPAARx) ... [Published Indianapolis Business Journal - Oct 09 2014]
First reported Oct 07 2014 - Updated Oct 08 2014 - 2 reports

Study: Carve-out Rx benefits offer advantages in cost, care

CHICAGO – Pharmacy benefits included as part of an employer's total health insurance package, known as a "carve-in" model, provide cost savings and more effective care, according to a study by the Blue Cross Blue Shield Association and Prime Therapeu ... [Published Chain Drug Review - Oct 08 2014]
First reported Oct 06 2014 - Updated Oct 06 2014 - 2 reports

Prime Therapeutics, Johns Hopkins publish research on specialty drug copay coupons in Health Affairs

ST. PAUL, Minn.Specialty medicines are becoming more common as they're used to treat many complex health conditions such as cancer, rheumatoid arthritis and multiple sclerosis. In fact, Prime predicts specialty drug costs will comprise half of total drug ... [Published BusinessWeek - Oct 06 2014]
First reported Oct 06 2014 - Updated Oct 06 2014 - 1 reports

Blue Cross Blue Shield Association and Prime Therapeutics Study Demonstrates Health Benefits and Cost Savings of Pharmacy Benefit Integration within Insurance Plans

CHICAGO, Oct. 6, 2014 /PRNewswire/ -- Blue Cross Blue Shield Association (BCBSA) and Prime Therapeutics LLC (Prime) today released a study demonstrating clear health benefits and cost savings of including pharmacy benefits as part of an employer's total ... [Published PR Newswire: General Business - Oct 06 2014]
First reported Oct 01 2014 - Updated Oct 01 2014 - 2 reports

Rising Generic Drug Prices Affect Pharmacies, Insurers Alike, Reports AIS Newsletter

Generic drug prices are on the rise, with half of all retail generics increasing in price in the last 12 months. For its Sept. 26 issue, Atlantic Information Services, Inc.’s (AIS) Drug Benefit News (DBN) interviewed a plan sponsor and a financial analyst ... [Published Bio-Medicine - Oct 01 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs

ST. PAUL, Minn., Sept. 30, 2014 /PRNewswire/ -- In 2011, approximately 5.1 million people in the United States abused prescription pain relievers (e.g. opioids).1 Clinical treatments for opioid dependence include detoxification or maintenance treatment, ... [Published TickerTech.com - Sep 30 2014]

Quotes

...saw a dramatic increase in prescriptions for the drug," said Peter Wickersham , senior vice president for integrated care and specialty at Prime. "In recent months, we've seen Sovaldi's use taper off in anticipation of this new drug."
"By reducing cost sharing, coupons may also circumvent efforts to encourage patients to use the most cost-effective drugs" the authors write
...will bear, I promise you it's not sustainable," Steven Miller, chief medical officer at PBM Express Scripts ($ESRX), told The Wall Street Journal. "We need to start the debate about how we get to a more sustainable model" of drug pricing
...approximately $100,000 per treatment regimen it's important to do all we can to help members take their medicines as prescribed," said Wickersham. "Health plans need to work closely with their pharmacy benefit managers to effectively manage these drugs."

More Content

All (50) | News (40) | Reports (0) | Blogs (9) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
The Future Contact Center Summit Announces Keyn... [Published InvestorPoint.com - 2 hours ago]
Gilead Sciences : Prime Therapeutics responds t... [Published 4 Traders - Oct 23 2014]
Drug coupons shrink patients' costs considerably [Published Medical Xpress - Oct 22 2014]
Specialty drugs -- Cost, impact & value: Health... [Published Press News.org - Oct 20 2014]
Pulling Back the Curtains on Obamacare Rx Usage [Published Pharmaceutical Executive - Oct 15 2014]
Blu Dot co-founder addresses design crowd at U ... [Published Minnesota Business - Oct 15 2014]
Payers hit back at Gilead for $94,500 price tag... [Published FiercePharma - Oct 13 2014]
Movers and Shakers: Duane Barnes, Prime Therape... [Published Minneapolis Star Tribune - Oct 12 2014]
FDA approves Gilead’s Harvoni, the first combo ... [Published Pharma Letter - Oct 12 2014]
Prime Therapeutics responds to FDA approval of ... [Published Bio-Medicine - Oct 11 2014]
Prime Therapeutics responds to FDA approval of ... [Published SearchBug - Oct 10 2014]
Prime Therapeutics responds to FDA approval of ... [Published Wall Street Select - Oct 10 2014]
Prime Therapeutics responds to FDA approval of ... [Published PR Newswire: Health - Oct 10 2014]
Click Here For Links From Oct. 10, 2014 [Published CBS Minnesota - Oct 10 2014]
Bringing people together to talk about 'big data' [Published SAS - Oct 10 2014]
Specialty prescription costs hurt across the board [Published Medical Marketing And Media - Oct 09 2014]
Duane Barnes, Prime Therapeutics' COO, Joins NA... [Published Indianapolis Business Journal - Oct 09 2014]
Duane Barnes, Prime Therapeutics' COO, Joins NA... [Published PR Newswire: General Business - Oct 09 2014]
Policy Changes Considered as Specialty Drug Spe... [Published American Journal of Public Health - Oct 09 2014]
Walgreens extends reach as Part D preferred pha... [Published Chain Drug Review - Oct 08 2014]
Studies: Exchange Enrollees Sicker Than Those W... [Published California Healthline - Oct 08 2014]
CCNG Announces November and December Contact Ce... [Published Insurance News Net - Oct 08 2014]
CCNG Announces November and December Contact Ce... [Published PRWeb - Oct 08 2014]
Study: Carve-out Rx benefits offer advantages i... [Published Chain Drug Review - Oct 08 2014]
Cost, use of opioid dependence treatment are in... [Published Formulary Journal - Oct 07 2014]
Integrated Pharmacy Benefits Have Significant C... [Published American Journal of Managed Care - Oct 07 2014]
Prime Therapeutics, Johns Hopkins publish resea... [Published BusinessWeek - Oct 06 2014]
Prime Therapeutics, Johns Hopkins publish resea... [Published PR Newswire: General Business - Oct 06 2014]
Blue Cross Blue Shield Association and Prime Th... [Published PR Newswire: General Business - Oct 06 2014]
Treating and preventing opioid abuse saves mone... [Published FierceHealthPayer - Oct 01 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Prime Therapeutics responds to FDA approval of ... [Published PR Newswire: Health - Oct 10 2014]
ST. PAUL, Minn., Oct. 10, 2014 /PRNewswire/ -- Today's U.S. Food and Drug Administration (FDA) approval of Gilead's new, fixed-dose, combination Hepatitis C drug signals another spike in treatment and pharmacy costs for health plans across the country, ...
Duane Barnes, Prime Therapeutics' COO, Joins NA... [Published PR Newswire: General Business - Oct 09 2014]
TAMPA, Fla., Oct. 9, 2014 /PRNewswire/ -- The National Association of Specialty Pharmacy (NASP) / Specialty Pharmacy Association of America (SPAARx) announced today that Duane Barnes, Chief Operating Officer (COO) for Prime Therapeutics LLC (Prime), has ...
Prime Therapeutics, Johns Hopkins publish resea... [Published PR Newswire: General Business - Oct 06 2014]
ST. PAUL, Minn., Oct. 6, 2014 /PRNewswire/ -- Today, the journal Health Affairs published its October issue focused on specialty medicines and included an article on copay coupons authored by researchers at Prime Therapeutics LLC (Prime) and Johns Hopkins ...
Blue Cross Blue Shield Association and Prime Th... [Published PR Newswire: General Business - Oct 06 2014]
CHICAGO, Oct. 6, 2014 /PRNewswire/ -- Blue Cross Blue Shield Association (BCBSA) and Prime Therapeutics LLC (Prime) today released a study demonstrating clear health benefits and cost savings of including pharmacy benefits as part of an employer's total ...
Prime Therapeutics' Wickersham delivers keynote... [Published PR Newswire: General Business - Sep 17 2014]
ST. PAUL, Minn., Sept. 17, 2014 /PRNewswire/ -- The United States doesn't have a singular prescription drug problem, we have a series of challenges related to safety, efficacy and cost, according to Peter Wickersham, senior vice president for Integrated ...
1 2

Press Releases

sort by: Date | Relevance
Professional Diversity Network Hosts Minneapoli... [Published PR Newswire - Jan 14 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.